Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment she has made of the potential implications for her policies of the statement by the CEO of Serum Institute in India, Adar Poonawalla, that the company has a stockpile of approximately 500,000 covid-19 vaccines.

The UK is committed to equitable, global access to COVID-19 vaccines and is one of the largest donors to COVAX. To date, COVAX has delivered over 738 million safe and effective vaccines to 144 participants. India, as the 'pharmacy of the world', will play a vital role in helping to meet international targets for global equitable access to COVID-19 vaccines in 2022. The UK and India will continue to work together as a Global Force for Good in health, as exemplified by the collaboration between Oxford University, AstraZeneca and the Serum Institute to develop COVID-19 vaccines at scale.